EXPRESSION PATTERNS OF TH1/TH2 TRANSCRIPTION FACTORS IN PATIENTS WITH GUTTATE PSORIASIS

被引:19
|
作者
Vanaki, Elaheh [1 ]
Ataei, Mitra [1 ]
Sanati, Mohammad Hossein [1 ]
Mansouri, Parvine [2 ]
Mahmoudi, Mahmoud [3 ]
Zarei, Feresteh [4 ]
Jadali, Zohreh
机构
[1] Natl Inst Genet Engn & Biotechnol, Dept Clin Genet, Tehran, Iran
[2] Univ Tehran Med Sci, Imam Khomeini Hosp, Dept Dermatol, Tehran, Iran
[3] Univ Tehran Med Sci, Sch Publ Hlth, Dept Biostat & Epidemiol, Tehran, Iran
[4] Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Parasitol & Mycol, Tehran, Iran
关键词
psoriasis; T cell; autoimmunity; INTERFERON-GAMMA; T-BET; CYTOKINES; DIFFERENTIATION; DISEASE; LESIONS; TYPE-1; CELLS;
D O I
10.1556/AMicr.60.2013.2.7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Many lines of evidence propose that psoriasis is a T cell-mediated disease where T cell activation is followed by secretion of inflammatory cytokines. To elucidate the functional state of T cells in guttate psoriasis, we analysed mRNA expression levels of T-bet and GATA-3 for Th1 and Th2 differentiation, respectively together with Th1 (IFN-gamma) and Th2 (IL-4) cytokine mRNA expression. Relative quantification of T-bet, GATA-3, IFN-gamma and Th2, and IL-4 transcripts in peripheral blood leukocytes (PBL) was conducted by real-time reverse transcriptase PCR (RT-PCR). Serum levels of IFN-gamma and Th2 and IL-4 were also determined by ELISA. GATA-3 and IL-4 mRNA expression levels were lower in psoriatic patients as compared to normal healthy controls. The expression levels of T-bet and IFN-gamma and Th2 genes were relatively similar in the patients and controls. In addition, a marked decrease in plasma IL-4 levels was observed in the psoriasis group, while no differences were observed with regard to levels of IFN-g and Th2 between patients and normal subjects. Furthermore, a clear correlation between decreased IL-4 mRNA expression and IL-4 (P < 0.05) was revealed. These results suggested that altered balance between Th1 and Th2 cells transcription factor genes and they products may be implicated in the pathogenesis of psoriasis.
引用
收藏
页码:163 / 174
页数:12
相关论文
共 50 条
  • [21] MATHEMATICAL INSIGHTS ON PSORIASIS REGULATION: ROLE OF Th1 AND Th2 CELLS
    Roy, Amit Kumar
    Roy, Priti Kumar
    Grigorieva, Ellina
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2018, 15 (03) : 717 - 738
  • [22] Th1/Th2 cells
    Romagnani, S
    INFLAMMATORY BOWEL DISEASES, 1999, 5 (04) : 285 - 294
  • [23] The Th1/Th2 paradigm
    Romagnani, S
    IMMUNOLOGY TODAY, 1997, 18 (06): : 263 - 266
  • [24] Th1/Th2 in aspergillosis
    Stevens, David A.
    MEDICAL MYCOLOGY, 2006, 44 : S229 - S235
  • [25] Chronic rhinosinusitis and psoriasis: do mutually exclusive systemic Th1 and Th2 disease patterns exist?
    Rashid, Rashid M.
    Miller, Andrew
    Scianna, Joseph M.
    Stankiewicz, James A.
    ACTA OTO-LARYNGOLOGICA, 2007, 127 (07) : 780 - 783
  • [26] Expression and secretion levels of Th1 and Th2 cytokines in patients with aggressive periodontitis
    Gonzales, J. R.
    Groeger, Sabine
    Boedeker, Rolf-Hasso
    Meyle, Joerg
    CLINICAL ORAL INVESTIGATIONS, 2012, 16 (05) : 1463 - 1473
  • [27] mRNA expression of interleukins and Th1/Th2 imbalance in patients with pulmonary embolism
    Duan, Qianglin
    Lv, Wei
    Wang, Lemin
    Gong, Zhu
    Wang, Qiang
    Song, Haoming
    Wang, Hao
    MOLECULAR MEDICINE REPORTS, 2013, 7 (01) : 332 - 336
  • [28] Expression and secretion levels of Th1 and Th2 cytokines in patients with aggressive periodontitis
    J. R. Gonzales
    Sabine Gröger
    Rolf-Hasso Boedeker
    Jörg Meyle
    Clinical Oral Investigations, 2012, 16 : 1463 - 1473
  • [29] Characterization of Th1/Th2 profile in uremic patients
    Nitta, K
    Akiba, T
    Kawashima, A
    Kimata, N
    Miwa, N
    Nishida, E
    Uchida, K
    Honda, K
    Yumura, W
    Nihei, H
    NEPHRON, 2002, 91 (03): : 492 - 495
  • [30] Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2)
    Phenekos, C
    Vryonidou, A
    Gritzapis, AD
    Baxevanis, CN
    Goula, M
    Papamichail, M
    NEUROIMMUNOMODULATION, 2004, 11 (04) : 209 - 213